Niagen Bioscience, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
NAGE on Nasdaq
Industry
Medicinal Chemicals & Botanical Products
Location
10900 Wilshire Blvd, Suite 600, Los Angeles, CA

Insiders trading volume in the past year

Niagen Bioscience, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Chau Hoi Shuen Solina Holly 10%+ Owner $27.2M Sep 30, 2022
Champion River Ventures Ltd Director, 10%+ Owner $16.1M Sep 6, 2023
Frank L. Jaksch Jr Director $14.4M -$230K -1.58% Dec 13, 2024
Robert N. Fried Chief Executive Officer, Director $5.43M Apr 9, 2025
Brianna Gerber Chief Financial Officer $40.4K Feb 22, 2024
Ozan Pamir Chief Financial Officer $21.4K +$21.4K Feb 12, 2025
Carlos Luis Lopez SVP, General Counsel $17.7K +$2.15K +13.8% Mar 7, 2025
Li Ka Shing 10%+ Owner $0 Sep 6, 2023
Kristin Patrick Director $0 -$82.1K -100% Aug 23, 2024
Jeong James Lee Interim CFO Jul 16, 2024
Ann Cohen Director Jun 20, 2024
Tsz Ho Tony LAU Director Jun 17, 2021
Steven D. Rubin Director Jun 20, 2024
Wing Tak Wendy YU Director Jun 20, 2024
Wang Yu Gary Ng Director Jun 20, 2024
Kevin M. Farr Chief Financial Officer Aug 12, 2022
Jeff Baxter Director Jun 17, 2021
Hamed Shahbazi Director Jun 20, 2024
Stephen A. Block Director Jun 17, 2021
Kurt A. Gustafson Director Jun 17, 2021
Caroline S. Levy Director Dec 1, 2021

Recent Insider Transactions by Companies or Individuals for Niagen Bioscience, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.